Exocrine Pancreatic Insufficiency: The Diagnosis Hiding Inside IBS
EPI leaves food half-digested while wearing an IBS label. The risk-factor company it keeps, the single stool test that finds it, and the enzyme-replacement learning curve patients describe.
· By Shashank Bhosale
The press does not currently name a clinical reviewer of record. Read about contributor roles and the review process before using health information. Editors & Contributors.
Chronic diarrhea, stools that float and shine with unabsorbed fat, weight sliding despite eating, bloating after every meal, and — beneath it all — vitamins quietly depleting: exocrine pancreatic insufficiency is the digestive diagnosis the literature calls substantially underrecognized, hiding in plain sight inside IBS labels while the actual problem goes untreated. The pancreas has simply stopped supplying enough digestive enzymes, and food is passing through half-claimed.
Who the research says to suspect it in
EPI rarely arrives from nowhere. The documented company it keeps: chronic pancreatitis above all; pancreatic surgery or cancer; cystic fibrosis; celiac disease; and — the association patients hear about least — longstanding diabetes, where the enzyme-producing pancreas can fail alongside the insulin-producing one. Accounts consistently feature years of “IBS” or food-intolerance labels before anyone connects the fatty stools and the risk factors and orders the unglamorous test that answers it: a stool elastase measurement.
What treatment actually looks like
The therapy is replacement, and patients describe it as transformative and fiddly in equal measure: pancreatic enzyme capsules — PERT — taken with every meal and snack, dosed to the fat content of the food, swallowed at the right point in the meal to travel with it. The learning curve fills the accounts: doses that need titrating up (underdosing is the classic reason “the enzymes don't work”), snacks that get forgotten, restaurant logistics, and the astonishment when it clicks — formed stools, weight stabilizing, energy returning as fat-soluble vitamins finally absorb. The literature adds the follow-through: monitoring vitamins A, D, E, and K, bone density over time, and the underlying condition driving it all.
The sentence patients suggest
For anyone with the risk factors and the symptoms: “Could we check a fecal elastase?” — a single question that accounts describe ending years of dietary self-blame.
Fifty first-person accounts of digestion decoded live on our Gut & Digestive Health shelf; our IBS companion maps the label this condition hides inside.
Companion reading, not medical advice. Persistent fatty stools, weight loss, or post-meal misery deserve evaluation — especially with pancreatic or diabetic history.
The Reading Room publishes personal stories and editorial notes from our press. Everything here is companion reading — never medical advice, diagnosis, or treatment. For guidance about your own health, please speak with a qualified clinician. Read how we collect and edit patient testimony in our Editorial Standards, or meet the press at The Masthead.
If this piece was useful, the volumes below hold fifty full-length accounts from people who have been through it — the part an article can only summarise.
